The state of Iowa currently has 3 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Iowa City, Des Moines, Sioux City and Cedar Rapids.
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
NCT03650114
Recruiting
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
04/17/2024
Locations: Mercy Ruan Neurology Clinic Res Ct., Des Moines, Iowa
Conditions: Relapsing Multiple Sclerosis
Register for Updates
Efficacy of Diet on Quality of Life in Multiple Sclerosis
NCT05007483
Recruiting
The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interventions (time restricted olive oil based (TROO) ketogenic and modified Paleolithic elimination) on MS QoL compared to usual care control (Dietary Guidelines for America), and the secondary objectives a... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
07/11/2023
Locations: Univeristy of Iowa, Iowa City, Iowa
Conditions: Multiple Sclerosis, Relapsing-Remitting
Register for Updates
Autoimmune Intervention Mastery Course Study
NCT05057676
Recruiting
The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, and post acute sequela of covid
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
07/10/2023
Locations: Univeristy of Iowa, Iowa City, Iowa
Conditions: Multiple Sclerosis, Clinically Isolated Syndrome, Fibromyalgia, Post Acute Sequelae of COVID-19
Register for Updates